Surgical management with enucleation was the primary treatment for uveal melanoma (UM) for over 100 years. The Collaborative Ocular Melanoma Study confirmed in 2001 that globe-preserving episcleral brachytherapy for UM was safe and effective, demonstrating no survival difference with enucleation. Today, brachytherapy is the most common form of radiotherapy for UM. We review the history of brachytherapy in the treatment of UM and the evolution of the procedure to incorporate fine-needle-aspiration biopsy techniques with DNA- and RNA-based genetic prognostic testing.
CITATION STYLE
Brewington, B. Y., Shao, Y. F., Davidorf, F. H., & Cebulla, C. M. (2018, May 17). Brachytherapy for patients with uveal melanoma: Historical perspectives and future treatment directions. Clinical Ophthalmology. Dove Medical Press Ltd. https://doi.org/10.2147/OPTH.S129645
Mendeley helps you to discover research relevant for your work.